1. Changes in methadone take-home dosing before and after COVID-19;Amram;Journal of Substance Abuse Treatment,2021
2. Validation of self-reported opioid agonist treatment among people who inject drugs using prescription dispensation records;Bouck;Epidemiology,2022
3. Management of opioid use disorders: A national clinical practice guideline;Bruneau;Canadian Medical Association Journal,2018
4. Canadian Centre on Substance Use and Addiction. (2020). Impacts of the COVID-19 pandemic on substance use treatment capacity in Canada. https://www.ccsa.ca/sites/default/files/2020-12/CCSA-COVID-19-Impacts-Pandemic-Substance-Use-Treatment-Capacity-Canada-2020-en.pdf.
5. Centre for Addiction and Mental Health. (2021). Opioid agonist therapy: A synthesis of canadian guidelines for treating opioid use disorder. 52.